Evidence map›Paper›PMID 35903774›Full record

ArticlemicroPublication biology2022

David V Begelman, Georgia Woods, Dipa Bhaumik, Suzanne Angeli, Anna C Foulger, Mark Lucanic, Jianfeng Lan, Julie K Andersen, Gordon J Lithgow

Open access · greenAbstract read
In one paragraph

Article in microPublication biology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
0.5field-weighted citation impact, top 38% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 6 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 2 institutions in 2 countries.

David V BegelmanThe Buck Institute for Research on Aging.
Georgia WoodsThe Buck Institute for Research on Aging.
Dipa BhaumikThe Buck Institute for Research on Aging.
Suzanne AngeliUniversity of Maine, Molecular & Biomedical Sciences.
Anna C FoulgerThe Buck Institute for Research on Aging.
Mark LucanicGeroStateAlpha.
Jianfeng LanGuangxi Key Laboratory of Molecular Medicine in Liver Injury and Repair, the Affiliated Hospital of Guilin Medical University, Guilin, 541001, Guangxi, China.
Julie K AndersenThe Buck Institute for Research on Aging.
Gordon J LithgowThe Buck Institute for Research on Aging.
Buck Institute for Research on Aging · USGuilin Medical University · CN

Funding

Neuronal FXR as a potential therapeutic target for Alzheimer's diseaseR01AG067325 · NIA · BUCK INSTITUTE FOR RESEARCH ON AGING · PI ANDERSEN, JULIE KAY, LITHGOW, GORDON J · 2020 to 2024
$3.1M
A temporal bioenergetic, metabolomics, and proteomic map of Alzheimer's disease in invertebrate modelsRF1AG057358 · NIA · BUCK INSTITUTE FOR RESEARCH ON AGING · PI ANDERSEN, JULIE KAY, LITHGOW, GORDON J · 2017 to 2017
$3.0M
NIA NIH HHS R01 AG067325NIA NIH HHS RF1 AG057358
6 · The paper itself

Abstract

We used CRISPR/Cas9 gene editing in

Identifiers

PMID35903774
PMCPMC9315405
OpenAlexW4288785136

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.